Patent · US Active

Screening method, a kit, a method of treatment and a compound for use in a method of treatment

US9784726B2 · kind B2 · utility

8Cited by
1References
8Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJan 8, 2014
Grant dateOct 10, 2017
Priority date
Expiry dateJan 8, 2034

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/566
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method of screening for a candidate compound for the treatment of a condition involving dysregulation of metabolism in a mammal, said method comprising bringing a compound into contact with at least one population of cells, comprising cells that express mTOR and Akt and that are capable of activating mTORC2 and Akt; determining mTORC2 activity and Akt activity in cells brought into contact with the compound, and identifying the candidate compound based on the determined mTORC2 activity and Akt activity. A kit for use in such a method of. A compound for use in a method of treatment of a condition involving dysregulation of metabolism in a mammal, and a method of treatment of such a condition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.